NDC 81033-104
Atovaquone 750 mg per 5 mL suspension
On the label: Kesin Pharma Corporation. It's repackaged: Kesin Pharma Corporation rebottles it from Bionpharma Inc.'s NDC 69452-252.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Corerx, Inc. | Clearwater, FL, United States | Makes it | Problems found, fixed voluntarilyFeb 26, 2026 · 5 inspections |
Repackaging site
- Kesin Pharma Corporation, Oldsmar, FL, United States · repackages it
- Kesin Pharma Corporation, Oldsmar, FL, United States · repackages it
Recalls
- Sep 17, 2024 · Class I · Bionpharma Inc.
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
Lots: Lot # 2310083, Exp. 09/30/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Atovaquone: every company that makes it
- Form
- suspension, oral
- Strength
- 750 mg per 5 mL
- Approval
- ANDA ANDA212918
- On the market since
- Jun 17, 2024
- Package NDCs
81033-104-0581033-104-2281033-104-4281033-104-50- Official label
- DailyMed (National Library of Medicine), updated Sep 15, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?